KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogenomics (NEO) Interest Expenses (2018 - 2025)

Historic Interest Expenses for Neogenomics (NEO) over the last 13 years, with Q4 2025 value amounting to $599000.0.

  • Neogenomics' Interest Expenses fell 6311.58% to $599000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $3.8 million, marking a year-over-year decrease of 4328.25%. This contributed to the annual value of $3.8 million for FY2025, which is 4328.25% down from last year.
  • Per Neogenomics' latest filing, its Interest Expenses stood at $599000.0 for Q4 2025, which was down 6311.58% from $603000.0 recorded in Q3 2025.
  • Neogenomics' 5-year Interest Expenses high stood at $5.2 million for Q4 2022, and its period low was $139000.0 during Q3 2022.
  • Its 5-year average for Interest Expenses is $1.7 million, with a median of $1.6 million in 2024.
  • As far as peak fluctuations go, Neogenomics' Interest Expenses plummeted by 8927.47% in 2022, and later soared by 111223.02% in 2023.
  • Over the past 5 years, Neogenomics' Interest Expenses (Quarter) stood at $4.8 million in 2021, then rose by 7.64% to $5.2 million in 2022, then plummeted by 67.77% to $1.7 million in 2023, then fell by 3.39% to $1.6 million in 2024, then tumbled by 63.12% to $599000.0 in 2025.
  • Its Interest Expenses stands at $599000.0 for Q4 2025, versus $603000.0 for Q3 2025 and $933000.0 for Q2 2025.